Современные данные и перспективы исследований больных с атеросклеротическим стенозом почечных артерий с точки зрения интервенционного лечения

Атеросклеротический стеноз почечных артерий (АСПА) – это состояние, при котором почечные артерии сужаются вследствие атеросклероза, что приводит к снижению притока крови к почкам и различным почечным осложнениям. Эффективность интервенционных методов лечения, таких как ангиопластика почечных артерий и стентирование, остается предметом дискуссий, что затрудняет отбор пациентов для этих процедур. 

Данный обзор посвящен диагностике и лечению АСПА с особым акцентом на потенциальную роль функциональной магнитно-резонансной томографии (МРТ) в оценке функции почек и механизмов ее развития. Обобщая современные подходы к диагностике и результаты интервенционного лечения, в обзоре подчеркивается важность принятия обоснованных клинических решений при ведении пациентов с АСПА. Функциональная МРТ становится многообещающим неинвазивным инструментом для оценки функции почек, помогающим в стратификации пациентов и планировании лечения.

Заключение. Эффективность интервенционных методов лечения АСПА требует дальнейшего изучения и тщательного отбора пациентов. Функциональная МРТ является перспективным неинвазивным методом оценки функции почек и механизмов, которые могут стать основой для принятия клинических решений при лечении АСПА. Развитие исследований в области методов диагностики, в частности функциональной МРТ, может расширить наше понимание и улучшить результаты лечения АСПА.

1. Dobrek L. An outline of renal artery stenosis pathophysiology-a narrative review. // Life – 2021. – 11(3) – P. 208.

2. Mishima E. Selection of patients for angioplasty for treatment of atherosclerotic renovascular disease: pre- dicting responsive patients./ Mishima E., Suzuki T., Ito S.// Am J Hypertens – 2020. – 33(5) – P.391–401.

3. Triantis G. Renal artery revascularization is a controversial treatment strategy for renal artery stenosis: a case series and a brief review of the current literature. /Triantis G., Chalikias G.K., Ioannidis E., Dagre A., Tziakas D.N. //Hellenic J Cardiol – 2022. – 65– P. 42-8.

4. Schoepe R. Atherosclerotic renal artery stenosis./ Schoepe R., McQuillan S., Valsan D., Teehan G., [et al.] // Adv Exp Med Biol. – 2017. – 956 – P. 2609–13.

5. Prince M. When and how should we revascularize patients with atherosclerotic renal artery stenosis?/ Prince M., Tafur J.D., White C.J. // JACC Cardiovasc Interv– 2019. –12(6) – P. 505–17.

6. Reinhard M. Renal artery stenting in consecutive high risk patients with atherosclerotic renovascular dis ease: a prospective 2-center cohort study./ Reinhard M., Schousboe K.., Andersen UB., Buus N.H., Rantanen J.M., Bech. J.N., [et al.] // J Am Heart Assoc. – 2022. - 11(7). – P. 421.

7. Bhalla V. Revascularization for renovascular disease: a scientific statement from the American Heart Association./ Bhalla V., Textor S.C., Beckman J.A., Casanegra A.I., Cooper C.J., Kim E.S.H., et al. // Hypertension. 2022. –79(8) – P. 128–43.

8. Kabłak-Ziembicka A. Simple clinical scores to predict blood pressure and renal function response to renal artery stenting for atherosclerotic renal artery stenosis./ Kabłak-Ziembicka A., Rosławiecka A., Badacz R., Sokołowski A., Rzeźnik D., Trystuła M., [et al.] // Pol Arch Intern Med. – 2020. –130(11) – P. 953–9.

9. Badacz R. The maintained glycemic target goal and renal function are associated with cardiovascular and renal outcomes in diabetic patients following stent-supported angioplasty for renovascular atherosclerotic disease./ Badacz R., Kabłak-Ziembicka A., Rosławiecka A., Rzeźnik D., Baran J.., Trystuła M, [et al.] // J Pers Med. – 2022. – 12(4) – Р. 537.

10. Mao W. Capability of arterial spin labeling and intravoxel incoherent motion diffusion weighted imaging to detect early kidney injury in chronic kidney disease. / Mao W., Ding Y., Ding X., Fu C., Cao B., Kuehn B., [et al.] // Eur Radiol. – 2023. – 33(5) – P. 3286–94.

11. Park B.K. Gray-scale, color Doppler, spectral Doppler, and contrast-enhanced renal artery ultrasound: imaging techniques and features.// J Clin Med. – 2022. –11(14) – P. 3961.

12. Aguet J. Contrast-enhanced body magnetic resonance angiography: how we do it. / Aguet J., Gill N., Tassos V.P., Chavhan G.B., Lam C.Z. //Pediatr Radiol. – 2022. – 52(2) – P. 262–70.

13. Orman G. Diagnostic sensitivity and specificity of CT angiography for renal artery stenosis in children. / Orman G., Masand P.M.., Kukreja KU., Acosta A.A., Guillerman R.P., Jadhav S.P. //Pediatr Radiol. – 2021. – 51(3) – P. 419–26.

14. Guo X. Renal artery assessment with non-enhanced MR angiography versus digital subtraction angiography: comparison between 1.5 and 3.0 T./ Guo X., Gong Y., Wu Z., Yan. F, Ding X., Xu X. // Eur Radiol. – 2020. –30(3) – P.1747–54.

15. Lal H. Non-contrast MR angiography versus contrast enhanced MR angiography for detection of renal artery stenosis: a comparative analysis in 400 renal arteries./ Lal H., Singh R.K.R., Yadav P., Yadav A., Bhadauria D., Singh A. // Abdom Radiol. – 2021.–46(5) – P. 2064–71.

16. Morita K. Non contrast renal MRA using multishot gradient echo EPI at 3T MRI./ Morita K., Nakaura T., Yoneyama M., Nagayama Y., Kidoh M., Uetani H., [et al.] // Eur Radiol. – 2021. – 31(8) – P. 5959–66.

17. Eirin A.. Emerging paradigms in chronic kidney ischemia. / Eirin A., Textor S.C., Lerman L.O.// Hypertension. – 2018.–72(5) – P.1023–30.

18. Lin Z. Prediction of split renal function improvement after renal artery stenting by blood oxygen level-dependent magnetic resonance imaging./ Lin Z., Zhang B., Lin L., Wang R., Niu G., Yan Z., [et al.] // Front Cardiovasc Med. –2022. –9 – P.793-777.

19. Nery F. Consensus-based technical recommendations for clinical translation of renal ASL MRI./ Nery F., Buchanan C.E., Harteveld A.A., Odudu A., Bane O., Cox E.F., [et al.] // Magma. – 2020. – 33(1) – P.141–61.

20. Kishida T. Editorial Comment to Magnetic resonance imaging of in vitro urine flow in single and tandem stented ureters subject to extrinsic ureteral obstruction.// Int J Urol. –2022. –29(10) – P.1227.

21. Zhang H.M. Arterial spin labeling MRI for predicting microvascular invasion of T1 staging renal clear cell carcinoma preoperatively./ Zhang H.M., Wen D.G., Wang Y., Bao Y.G., Yuan Y., Chen Y.T., [et al.] // Front Oncol. – 2021. –№11 – P. 644-975.

22. Chhabra J. The role of arterial spin labeling functional MRI in assessing perfusion impairment of renal allografts: a systematic review./ Chhabra J., Karwarker G.V., Rajamanuri M., Maligireddy A.R., Dai E., Chahal M., [et al.] // Cureus. – 2022. – 14(5) – P. 254-28.

23. Romero C.A. Noninvasive measurement of renal blood flow by magnetic resonance imaging in rats./ Romero C.A., Cabral G., Knight R.A., Ding G., Peterson E.L., Carretero O.A. // Am J Physiol Ren Physiol. – 2018. –314(1) – P. 99–106.

24. Yin L. The value of magnetic resonance blood oxygen level-dependent imaging in evaluating the efficacy of advanced cervical cancer combined with radiotherapy and chemotherapy./ Yin L., Zhuang X., Li J.L.// Acta Radiol. –2022. – №4 – P. 284-302.

25. Magawa S. Evaluation of placental oxygenation index using blood oxygen level-dependent magnetic resonance imaging (BOLD-MRI) during normal late pregnancy./ Magawa S., Nii M., Ishida M., Takase S., Nakayama R., Enomoto N., [et al.] // J Matern Fetal Neonatal Med. – 2022.–35(25) – P. 5274–81.

26. You W. Hemodynamic responses of the placenta and brain to maternal hyperoxia in fetuses with congenital heart disease by using blood oxygen-level dependent MRI./ You W., Andescavage N.N., Kapse K., Donofrio M.T., Jacobs M., Limperopoulos C. // Radiology. – 2020. – 294(1) – P.141–8.

27. Lal H. Role of blood oxygen level dependent magnetic resonance imaging in studying renal oxygenation changes in renal artery stenosis./ Lal H., Singh P.., Ponmalai K, Prasad R., Singh S.P., Yadav P., [et al.] // Abdom Radiol. – 2022. – 47(3) – P.1112–23.

28. Li X. Perfusion and oxygenation in allografts with transplant renal artery stenosis: evaluation with functional magnetic resonance imaging./ Li X., Wang W., Cheng D., Yu Y., Wu Q., Ni X., [et al.] // Clin Transpl. – 2022. –36(11)– P. 4806.

29. Fu J. Diffusion kurtosis imaging in the pre diction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy./ Fu J., Tang L., Li Z.Y., Li X.T., Zhu H.F., Sun Y.S., et al. // Eur J Radiol. – 2020. –128–p.108-974.

30. Le Bihan D. What can we see with IVIM MRI?// Neuroimage. – 2019. –187– P. 56–67.

31. 31.Liang P. Noninvasive assessment of kidney dysfunction in children by using blood oxygenation level-dependent MRI and intravoxel incoherent motion diffusion-weighted imaging./ Liang P., Chen Y., Li S., Xu C., Yuan G., Hu D., [et al.] // Insights Imaging. –2021.– 21;12(1): – P.146.

32. L.E. Bihan. MR imaging ofintravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders./ L.E. Bihan D, Breton E., Lallemand D., Grenier. P, Cabanis E., Laval-Jeantet M. // Radiology. –1986. –161(2) – P. 401–7.

33. Herrmann S.M. Renovascular hypertension./ Herrmann S.M., Textor S.C. // Endocrinol Metab Clin North Am. – 2019. – 48(4) – P. 765–78.

34. Milani B. Image acquisition for intravoxel incoherent motion imaging of kidneys should be triggered at the instant of maximum blood velocity: evidence obtained with simulations and in vivo experiments./ Milani B., Ledoux J.B., Rotzinger D.C., Kanemitsu M., Vallée J.P., Burnier M., [et al.] // Magn Reson Med. –2019. –81(1) – P. 583–93.

35. Feng Y.Z. Intravoxel incoherent motion (IVIM) at 3.0 T: evaluation of early renal function changes in type 2 diabetic patients./ Feng Y.Z., Chen X.Q., Yu J., Liu X.L., Cheng Z.Y., Ren W.W., [et al.] // Abdom Radiol. – 2018. – 43(10). – P. 2764–73.

36. Ge X.Y. Diagnostic accuracy of ultrasoundbased multimodal radiomics modeling for fibrosis detection in chronic kidney disease./ Ge X.Y., Lan Z.K., Lan Q.Q., Lin H.S., Wang G.D., Chen J. // Eur Radiol. –2023. –33(4) – P. 2386–98.

37. Feng C. Artificial intelligence in renal pathology: current status and future. / Feng C., Liu F. // Bosn J Basic Med Sci. –2022. –14. – P. 26-34.

38. Alfieri F. External validation of a deep-learning model to predict severe acute kidney injury based on urine output changes in critically ill patients./ Alfieri F., Ancona A., Tripepi G., Randazzo V., Paviglianiti A., Pasero E, et al. // J Nephrol. –2022. – 35(8) – P. 2047–56.

39. Pan L. Evaluation of renal ischemia- reperfusion injury by magnetic resonance imaging texture analysis: an experimental study./ Pan L., Chen J., Zha T., Zou L., Zhang J., Jin P., [et al.] // Magn Reson Med. – 2021. –85(1) – P. 346–56.

40. Liang F. Using angiographic para- metric imaging-derived radiomics features to predict complications and embolization outcomes of intracranial aneurysms treated by pipeline embolization devices./ Liang F., Ma C., Zhu H., Liu L., Liang S., Jiang P., [et al.] // J Neurointerv Surg. –2022. –14(8) – P. 826–31